ARDELYX COMPLETES ENROLLMENT IN PHASE 3 ACCEL CLINICAL TRIAL OF IBSRELA® (TENAPANOR) IN ADULTS WITH CHRONIC IDIOPATHIC CONSTIPATION

Reuters · 6d ago

Please log in to view news